Skip to content

Study of Nutritional Suitability of a New Infant Formula for Term Infants

Study of Nutritional Suitability of a New Infant Formula for Term Infants

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02490852
Enrollment
304
Registered
2015-07-07
Start date
2015-08-31
Completion date
2018-08-22
Last updated
2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Growth

Brief summary

This is a growth study of full-term infants. The growth of infants fed the investigational formula will be compared with infants fed a control formula. A breastfeeding arm will be used as reference.

Interventions

OTHERActive Comparator: Commercially available Infant formula

fed ad libitum

OTHERActive Comparator: Human milk

fed ad libitum

Sponsors

Ausnutria Hyproca B.V.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
No minimum to 13 Days
Healthy volunteers
Yes

Inclusion criteria

* Healthy full term infant (37-42 weeks of gestational age) * Birth weight 2,500 to 4,500 g * Infant's mother willing and able to exclusively breast feed or infant's parent(s)/caregiver(s) willing to exclusively use randomized infant formula during study participation * Parent(s)/caregiver(s) able to attend visits and willing to complete the subject diary * Informed consent signed by parent(s)/caregiver(s)

Exclusion criteria

* Congenital illness or malformation that may affect infant feeding or normal growth * Gastrointestinal disorders * Suspected or known allergy to milk protein for formula groups * Known food allergies in parents or siblings for formula groups * Multiples * Readmission to hospital for longer than 3 days for another reason than hyperbilirubinemia prior to enrollment * Infant participating in another clinical study * Infant's family unable to comply with the protocol according to the investigators's assessment

Design outcomes

Primary

MeasureTime frame
Weight gain16 weeks

Countries

Austria, Croatia, Germany, Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026